According to the latest financial report from Novo Nordisk, in 2025, the sales of semaglutide in Greater China are expected to reach approximately 5.4 billion Danish kroner, equivalent to about 6.7 billion RMB, of which the diabetes version generated approximately 5.645 billion RMB in sales, nearly seven times the approximately 835 million RMB generated by the weight-loss version
Others tolerate 12mg well and appreciate the additional efficacy
Those with access to regular medical monitoring, including frequent bloodwork and body composition assessment
However, Wegovy may be covered when prescribed for cardiovascular risk reduction , and Zepbound may be covered for obstructive sleep apnea (OSA)
In stem cell models, it has been associated with increased integrin expression and markers of proliferative potential, raising interest in its role in regenerative contexts